Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-Center, Single-Dose, 3-Way Crossover Study of the Safety and Pharmacokinetics of Albuterol Administered by the Halix(TM) Albuterol Unit Dose Disposable Inhaler

NCT03373409 is registered in ClinicalTrials.gov with Concentrx Pharmaceuticals, Inc. as lead sponsor.

NCT NCT03373409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03373409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-Center, Single-Dose, 3-Way Crossover Study of the Safety and Pharmacokinetics of Albuterol Administered by the Halix(TM) Albuterol Unit Dose Disposable Inhaler
Lead sponsor
Concentrx Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2017
Completion date
July 25, 2018
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma